Viewing Study NCT04916860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-01-06 @ 4:02 AM
Study NCT ID: NCT04916860
Status: UNKNOWN
Last Update Posted: 2023-03-31
First Post: 2021-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or … View
Keywords: